Bladder cancer recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (UTUC) is a common occurrence. A new nomogram, based on retrospective analysis of a large multicentre ...

Credit: Shutterstock. The new guideline aims to limit toxicity and improve cancer control and survival in patients with UTUC. The American Urological Association (AUA) and Society of Urologic Oncology ...

When urologists convene, they often discuss the newest technologies that can help them better serve their patients. In the case of upper tract urothelial carcinoma (UTUC), an exciting treatment ...

blood test Since UTUC is frequently understaged, this predictive biomarker may improve management. Preoperative detection of plasma circulating tumor DNA (ctDNA) predicts muscle-invasive and non-organ ...

TEL AVIV, Israel, May 31, 2025 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

"Overall, we need to do a better job with biomarkers in this disease…We don’t have a good way to select our patients…There’s a lot of promise, a lot of interest, but we have to prospectively validate ...

Scientific advances have transformed how we treat cancer over the last decade. The advent of new types of cancer therapies, including targeted therapies and immunotherapies, have resulted in outcomes ...

Analysis of therapy attrition and changes in outcomes over time for patients (pts) with advanced urothelial cancer (aUC) treated at an academic center. This is an ASCO Meeting Abstract from the 2024 ...

Validation of 3-factor clinical-genomic model to predict response to atezolizumab as first-line or post-platinum therapy for advanced urothelial carcinoma. Association of positive Ki-67 and PD-L1 ...